Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8351241 | 0.97 | AGTR2 (1.00) | AGTR1AGTR2 | |
| SCHEMBL8348100 | 0.92 | AGTR2 (1.00) | AGTR1AGTR2 | |
| SCHEMBL7021272 | 0.90 | AGTR2 (1.00) | AGTR1AGTR2 | |
| SCHEMBL6544946 | 0.89 | AGTR2 (1.00) | AGTR1AGTR2 | |
| SCHEMBL7103027 | 0.89 | AGTR2 (0.76) | AGTR1AGTR2 | |
| SCHEMBL7026921 | 0.87 | AGTR1 (0.83) | AGTR1AGTR2 | |
| SCHEMBL8351247 | 0.87 | AGTR1 (1.00) | AGTR1AGTR2 | |
| SCHEMBL7101649 | 0.86 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL8901703 | 0.86 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL8976602 | 0.85 | AGTR2 (1.00) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0560177-B1 | Imidazole derivatives having biphenylsulphonylurea or biphenylsulfonylurethane side chains, process for their production and use thereof | HOECHST AG (DE) | 2003-01-08 | — | — | EP | disclosed |
| US-5604251-A | Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain and their use as angitensin II receptors | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-02-18 | — | — | US | disclosed |
| EP-0560177-A1 | Imidazole derivatives having biphenylsulphonylurea or biphenylsulfonylurethane side chains, process for their production and use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-09-15 | — | — | EP | disclosed |